Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 9Ganglioneuroblastoma 3Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Medulloblastoma 1Lung Neoplasms 1Kidney Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 18Temozolomide 11Vincristine 10Filgrastim 9Etoposide 9Granulocyte Colony-Stimulating Factor 8Carboplatin 8Cyclophosphamide 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Radiotherapy, Conformal 5Radiosurgery 5Peripheral Blood Stem Cell Transplantation 5Lomustine 5etoposide phosphate 4Thiotepa 3Immunohistochemistry 3Chemotherapy, Adjuvant 3Bevacizumab 3sargramostim 2Topotecan 2Psychiatric Rehabilitation 2Proton Therapy 2Procarbazine 2Microarray Analysis 2Mesna 2Mental Status and Dementia Tests 2Memantine 2In Situ Hybridization, Fluorescence 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Brain Neoplasms × Isotretinoin × Clear all
NCT00078988 2015-05-07

High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas

Children's Oncology Group

Phase 3 Completed
1 enrolled
CNS

Astrocytoma, Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡